<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
	<title>Medical Product Guide&#187; Cholesterol</title>
	<atom:link href="http://blog.medicalproductguide.com/category/pharmaceutical/cholesterol/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.medicalproductguide.com</link>
	<description>A comprehensive guide to medical products for medical professionals</description>
	<lastBuildDate>Mon, 20 Jun 2011 12:36:09 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
		<item>
		<title>Abbott receives FDA approval for cholesterol drug</title>
		<link>http://blog.medicalproductguide.com/2008/02/18/abbott-receives-fda-approval-for-cholesterol-drug/</link>
		<comments>http://blog.medicalproductguide.com/2008/02/18/abbott-receives-fda-approval-for-cholesterol-drug/#comments</comments>
		<pubDate>Mon, 18 Feb 2008 18:05:24 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Cholesterol]]></category>
		<category><![CDATA[FDA approvals]]></category>
		<category><![CDATA[Pharmaceutical products]]></category>
		<category><![CDATA[Abbott]]></category>
		<category><![CDATA[FDA approval]]></category>
		<category><![CDATA[Simcor]]></category>
		<category><![CDATA[simvastatin]]></category>
		<category><![CDATA[triglycerides]]></category>
		<guid isPermaLink="false">http://www.medicalproductguide.com/blog/2008/02/18/abbott-receives-fda-approval-for-cholesterol-drug/</guid>
		<description><![CDATA[Abbott Laboratories has received FDA approval for its cholesterol treatment Simcor. The drug is a combination of a statin called simvastatin, which lowers “bad” cholesterol, and Abbott&#8217;s Niaspan, an extended-release version of niacin, which raises “good” cholesterol. The drug also lowers triglycerides, a type of blood fats. Abbott is conducting a study to determine Simcor’s [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.abbott.com/">Abbott Laboratories</a> has receiv<img border="1" vspace="5" align="right" width="120" src="http://blog.medicalproductguide.com/files/2008/02/abbott.jpg" hspace="5" alt="Abbott Laboratories" height="42" />ed FDA approval for its cholesterol treatment Simcor. The drug is a combination of a statin called simvastatin, which lowers “bad” cholesterol, and Abbott&#8217;s Niaspan, an extended-release version of niacin, which raises “good” cholesterol. The drug also lowers triglycerides, a type of blood fats. Abbott is conducting a study to determine Simcor’s effectiveness in preventing heart attacks and strokes. The results of this study are expected in 2011.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.medicalproductguide.com/2008/02/18/abbott-receives-fda-approval-for-cholesterol-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Risk of metabolic syndrome up with meat, fried food</title>
		<link>http://blog.medicalproductguide.com/2008/01/25/risk-of-metabolic-syndrome-up-with-meat-fried-food/</link>
		<comments>http://blog.medicalproductguide.com/2008/01/25/risk-of-metabolic-syndrome-up-with-meat-fried-food/#comments</comments>
		<pubDate>Fri, 25 Jan 2008 15:16:00 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Blood pressure]]></category>
		<category><![CDATA[Cholesterol]]></category>
		<category><![CDATA[Lifestyle]]></category>
		<category><![CDATA[blood pressure]]></category>
		<category><![CDATA[blood sugar]]></category>
		<category><![CDATA[obesity]]></category>
		<guid isPermaLink="false">http://www.medicalproductguide.com/blog/2008/01/25/risk-of-metabolic-syndrome-up-with-meat-fried-food/</guid>
		<description><![CDATA[A diet comprising mainly of meat and fried foods increases the risk of developing metabolic syndrome, according to research published in Circulation: Journal of the American Heart Association. Metabolic syndrome refers to the presence of three or more cardiovascular risk factors, including obesity, high blood pressure, elevated blood sugar and low levels of HDL (high-density [...]]]></description>
			<content:encoded><![CDATA[<p>A diet comprising mainly of meat and fried foods increases the risk of developing metabolic syndrome, according to research published in <a href="http://circ.ahajournals.org/">Circulation: Journal of the American Heart Association</a>. Metabolic syndrome refers to the presence of three or more cardiovascular risk factors, including obesity, high blood pressure, elevated blood sugar and low levels of HDL (high-density lipoprotein or “good”) cholesterol.</p>
<p>The study also confirmed an earlier finding that the consumption of diet soda raises the risk of metabolic syndrome. Dairy products were found to prevent metabolic syndrome to some extent.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.medicalproductguide.com/2008/01/25/risk-of-metabolic-syndrome-up-with-meat-fried-food/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ENHANCE fails to enhance Vytorin prospects</title>
		<link>http://blog.medicalproductguide.com/2008/01/22/enhance-fails-to-enhance-vytorin-prospects/</link>
		<comments>http://blog.medicalproductguide.com/2008/01/22/enhance-fails-to-enhance-vytorin-prospects/#comments</comments>
		<pubDate>Tue, 22 Jan 2008 15:24:46 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Cardiology products]]></category>
		<category><![CDATA[Cholesterol]]></category>
		<category><![CDATA[Pharmaceutical products]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Schering]]></category>
		<category><![CDATA[Schering-Plough]]></category>
		<category><![CDATA[Vytorin]]></category>
		<category><![CDATA[Zetia]]></category>
		<category><![CDATA[Zocor]]></category>
		<guid isPermaLink="false">http://www.medicalproductguide.com/blog/2008/01/22/enhance-fails-to-enhance-vytorin-prospects/</guid>
		<description><![CDATA[Merck &#38; Co. and Schering-Plough Corp. are running newspaper ads to protect the reputation of the cholesterol-lowering Vytorin drug, after having announced disappointing results last week. The latest ENHANCE study, which aimed at measuring Vytorin’s ability to reduce clogged arteries, showed the drug to be only minimally more effective than a generic statin. Cardiologists are [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.merck.com/">Merck &amp; Co</a>. and <a href="http://www.sch-plough.com/schering_plough/index.jsp">Schering-Plough Corp</a>. are running newspaper ads to <img border="1" vspace="5" align="right" width="199" src="http://blog.medicalproductguide.com/files/2008/01/vytorin-logo.jpg" hspace="5" alt="Vytorin logo" height="69" />protect the reputation of the cholesterol-lowering <a href="http://www.vytorin.com/ezetimibe_simvastatin/vytorin/consumer/index.jsp">Vytorin drug</a>, after having announced disappointing results last week. The latest <a href="http://www.biospace.com/news_story.aspx?StoryId=82574">ENHANCE study</a>, which aimed at measuring Vytorin’s ability to reduce clogged arteries, showed the drug to be only minimally more effective than a generic statin. Cardiologists are now questioning the use of Vytorin, which combines Zetia and Zocor (or simvastatin) into one pill.</p>
<p>The ENHANCE study was only an initial study and was not as thorough as clinical trials.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.medicalproductguide.com/2008/01/22/enhance-fails-to-enhance-vytorin-prospects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Served from: blog.medicalproductguide.com @ 2012-02-08 14:29:45 -->
